We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sun Pharmaceutical said that the FDA will lift an import alert imposed on its Mohali manufacturing plant in India, allowing the company to begin shipping products from the facility to the US. Shares in the company rose as much as 7 percent on the news.